PT2687518T - Composto heterocíclico saturado contendo azoto - Google Patents

Composto heterocíclico saturado contendo azoto

Info

Publication number
PT2687518T
PT2687518T PT127575397T PT12757539T PT2687518T PT 2687518 T PT2687518 T PT 2687518T PT 127575397 T PT127575397 T PT 127575397T PT 12757539 T PT12757539 T PT 12757539T PT 2687518 T PT2687518 T PT 2687518T
Authority
PT
Portugal
Prior art keywords
hydrocyclic
containing nitrogen
saturated containing
compound saturated
compound
Prior art date
Application number
PT127575397T
Other languages
English (en)
Inventor
Kawaguchi Takayuki
Iijima Toru
Sugama Hiroshi
Shen Jingkang
Xia Guangxin
Xie Jianshu
Hirai Miki
Original Assignee
Mitsubishi Tanabe Pharma Corp
Shanghai Pharmaceuticals Holding Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Tanabe Pharma Corp, Shanghai Pharmaceuticals Holding Co Ltd filed Critical Mitsubishi Tanabe Pharma Corp
Publication of PT2687518T publication Critical patent/PT2687518T/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
PT127575397T 2011-03-16 2012-03-15 Composto heterocíclico saturado contendo azoto PT2687518T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2011058338 2011-03-16

Publications (1)

Publication Number Publication Date
PT2687518T true PT2687518T (pt) 2018-01-19

Family

ID=46830839

Family Applications (1)

Application Number Title Priority Date Filing Date
PT127575397T PT2687518T (pt) 2011-03-16 2012-03-15 Composto heterocíclico saturado contendo azoto

Country Status (18)

Country Link
US (2) US9278944B2 (pt)
EP (1) EP2687518B1 (pt)
JP (1) JP5760078B2 (pt)
KR (1) KR101651722B1 (pt)
CN (1) CN103562191B (pt)
AU (1) AU2012229859C1 (pt)
BR (1) BR112013023480B1 (pt)
CA (1) CA2828378C (pt)
DK (1) DK2687518T3 (pt)
ES (1) ES2652454T3 (pt)
HU (1) HUE037584T2 (pt)
MX (1) MX349484B (pt)
PH (1) PH12013501840A1 (pt)
PL (1) PL2687518T3 (pt)
PT (1) PT2687518T (pt)
RU (1) RU2595136C2 (pt)
TW (1) TWI597273B (pt)
WO (1) WO2012124775A1 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5764628B2 (ja) * 2012-09-14 2015-08-19 田辺三菱製薬株式会社 医薬組成物
WO2014042263A1 (ja) * 2012-09-14 2014-03-20 田辺三菱製薬株式会社 新規レニン阻害薬
CN113816951B (zh) * 2015-12-29 2022-09-27 上海医药集团股份有限公司 吗啉衍生物的盐及其晶型、其制备方法及药物组合物、用途
CN109705052B (zh) * 2019-01-25 2020-12-08 苏州大学 一种制备1,4-二氢噁嗪的方法
WO2022047730A1 (en) * 2020-09-04 2022-03-10 Shanghai Pharmaceuticals Holding Co., Ltd. Methods to treat inflammatory bowel disease
KR102898913B1 (ko) * 2020-09-04 2025-12-10 상하이 파마슈티컬스 홀딩 컴퍼니 리미티드 질소 함유 포화 헤테로사이클릭 화합물의 응용
CN118084737A (zh) * 2024-04-07 2024-05-28 江苏工程职业技术学院 4-(1-((叔丁氧基羰基)氨基)环丁基)苯甲酸的合成方法
CN120365731B (zh) * 2025-06-04 2025-12-16 浙江福莱新材料股份有限公司 一种高强度阻燃隔音隔热复合材料及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0119797D0 (en) * 2001-08-14 2001-10-03 Glaxo Group Ltd Chemical compounds
GB0428526D0 (en) 2004-12-30 2005-02-09 Novartis Ag Organic compounds
GB0505969D0 (en) * 2005-03-23 2005-04-27 Novartis Ag Organic compounds
DE102005017116A1 (de) 2005-04-13 2006-10-26 Novartis Ag Hemmstoffe für Inhibitoren von Apoptose Proteinen (IAP)
GB0511063D0 (en) * 2005-05-31 2005-07-06 Novartis Ag Organic compounds
TWI452044B (zh) * 2007-06-15 2014-09-11 Mitsubishi Tanabe Pharma Corp 嗎啉衍生物
US8440693B2 (en) 2009-12-22 2013-05-14 Novartis Ag Substituted isoquinolinones and quinazolinones
WO2014042263A1 (ja) * 2012-09-14 2014-03-20 田辺三菱製薬株式会社 新規レニン阻害薬

Also Published As

Publication number Publication date
MX2013010554A (es) 2013-12-02
MX349484B (es) 2017-07-31
KR101651722B1 (ko) 2016-08-26
TWI597273B (zh) 2017-09-01
WO2012124775A1 (ja) 2012-09-20
AU2012229859B2 (en) 2015-07-16
RU2595136C2 (ru) 2016-08-20
JP5760078B2 (ja) 2015-08-05
KR20130133294A (ko) 2013-12-06
CN103562191A (zh) 2014-02-05
DK2687518T3 (da) 2018-01-29
BR112013023480A8 (pt) 2019-07-09
BR112013023480A2 (pt) 2017-07-18
CN103562191B (zh) 2016-03-30
EP2687518A1 (en) 2014-01-22
RU2013146012A (ru) 2015-05-27
PH12013501840A1 (en) 2016-06-17
US9278944B2 (en) 2016-03-08
CA2828378A1 (en) 2012-09-20
EP2687518A4 (en) 2014-08-20
AU2012229859A1 (en) 2013-09-19
US20140011807A1 (en) 2014-01-09
EP2687518B1 (en) 2017-11-01
AU2012229859C1 (en) 2020-01-16
HUE037584T2 (hu) 2018-09-28
PL2687518T3 (pl) 2018-04-30
JPWO2012124775A1 (ja) 2014-07-24
BR112013023480B1 (pt) 2019-10-01
US20160145220A1 (en) 2016-05-26
ES2652454T3 (es) 2018-02-02
CA2828378C (en) 2017-11-14
TW201242955A (en) 2012-11-01
US10155731B2 (en) 2018-12-18

Similar Documents

Publication Publication Date Title
NL301233I2 (nl) spesolimab
LT2751083T (lt) Kvinolono junginys
CO6900145A2 (es) Compuesto de ciclopropanoamina
HRP20170226T1 (hr) Spoj pirazinkarboksamida
HUE060339T2 (hu) Szalag
HUE036259T2 (hu) Inhibitor vegyületek
IL229513A0 (en) Imidazopyridine compounds
CR20130231A (es) Compuestos antivirales
HRP20171005T1 (hr) Spojevi imidazopirolidinona
BR112014007781A2 (pt) compostos anti-virais
DOP2012000224A (es) Compuesto heterociclico
BR112014012016A2 (pt) compostos
EP2673344A4 (en) STABLE BIO OIL
CO6910197A2 (es) Compuestos novedosos
DK2678329T3 (da) Triazolopyridinforbindelser som pim-kinase-hæmmere
EP2881386A4 (en) amide
EP2721239A4 (en) TOOL CARRIER
SMT201600328B (it) Nuovi composti come inibitori di diacilglicerolo aciltransferasi
EP2753157A4 (en) FÖRDERBAND
LTC3246325I2 (lt) 2-acilaminotiazolo junginio kristalai
DK2804611T3 (da) Chitosanafledte forbindelser
EP2753158A4 (en) FÖRDERBAND
BR112013028029A2 (pt) composto
BR112015004938A2 (pt) combinações de compostos ativos
BR112012026803A2 (pt) composto